project id: TCGA-STAD; case submitter id: TCGA-IN-A6RO; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.76; rna integrity number: 9.2; age at index: 70; days to birth: -25789; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Dead; year of birth: 1942; age at diagnosis: 25789; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 150.0; sample id: c6e17043-a145-4cc3-b889-4f499b17dbf3; sample submitter id: TCGA-IN-A6RO-01A; portion id: e034fc78-a57c-48b4-a0e1-cbb7b0263519; portion submitter id: TCGA-IN-A6RO-01A-12; slide id: bee0497d-78d8-4c8a-bb60-e1042cf05f9e; slide submitter id: TCGA-IN-A6RO-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 1.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 19.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;